A New York investment firm founded by Eli Casdin that invests in life sciences companies on both public and private markets. Its venture list includes cancer companies such as Black Diamond Therapeutics and Function Oncology.
Casdin Capital, based at 1350 Avenue of the Americas in New York, describes itself as investing 'in all aspects of today's Life Sciences revolution' across healthcare, biotechnology, synthetic biology and technology. Eli Casdin is listed as Chief Investment Officer and Founder. The firm builds concentrated positions in public companies and also runs a venture programme, and was a sponsor of the CM Life Sciences special purpose acquisition vehicles. Its venture page shows logos rather than descriptions; oncology-related names visible there include Black Diamond Therapeutics (precision oncology), Function Oncology (functional genomics for cancer), Scorpion Therapeutics, C2i Genomics (cancer genomics) and the digital pathology company Paige.
| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Exai Bio Palo Alto, CA, US | Startup | diagnostics | Series A 2021, $68M | |
| Tango Therapeutics Boston, MA, US | Public | biotech | Pancreatic ductal adenocarcinomaNon-small-cell lung cancerGlioma & glioblastoma | IPO 2021, $353M |
Shares Exai Bio and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.
Shares Tango Therapeutics and the tag vc.